ArticleFrontiers in psychology2025
The therapeutic potential of thalassotherapy for enhancing well-being and reducing pharmaceutical costs in individuals with disabilities.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Thalassotherapy has shown promising effects on mental and physical well-being. However, its application among individuals with intellectual disabilities, psychiatric disorders, and cognitive impairments remains underexplored. This study evaluates the therapeutic potential of thalassotherapy in reducing pharmaceutical costs and improving well-being among individuals with intellectual disabilities, psychiatric disorders, and cognitive impairments. Materials and methods: This is an interventional cohort study that involved 144 participants aged 18 to 64 from two residential facilities in Apulia, Italy in 8 weeks. The intervention utilized seawater-based therapies at a certified thalassotherapy center, incorporating muscle awakening, music therapy, and group workshops. Participants underwent psychometric assessments using the VADO, Hamilton Anxiety Rating Scale (HAM-A), and Beck Depression Inventory (BDI) before and after the treatment. Results: Thalssotherpy indicated significant reductions in anxiety and depression scores. Specifically, repeated measures ANCOVA revealed a notable decrease in HAM-A ( Discussion: The findings align with previous research on water-based therapies, highlighting thalassotherapy's holistic benefits. Importantly, the study demonstrates the potential to reduce pharmaceutical dependence, thereby lowering healthcare costs and minimizing medication side effects. Despite its promising outcomes, the research acknowledges limitations, including a relatively small sample size and lack of long-term follow-up. Future studies with larger, diverse populations and controlled comparisons are necessary to validate the sustainability and broader applicability of these findings. Overall, thalassotherapy emerges as a cost-effective, non-pharmacological intervention that can complement traditional treatments, offering a valuable approach to enhancing the physical and psychological health of individuals with disabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.